Skip to Content
Merck
  • Urinary sodium and potassium excretion, mortality, and cardiovascular events.

Urinary sodium and potassium excretion, mortality, and cardiovascular events.

The New England journal of medicine (2014-08-15)
Martin O'Donnell, Andrew Mente, Sumathy Rangarajan, Matthew J McQueen, Xingyu Wang, Lisheng Liu, Hou Yan, Shun Fu Lee, Prem Mony, Anitha Devanath, Annika Rosengren, Patricio Lopez-Jaramillo, Rafael Diaz, Alvaro Avezum, Fernando Lanas, Khalid Yusoff, Romaina Iqbal, Rafal Ilow, Noushin Mohammadifard, Sadi Gulec, Afzal Hussein Yusufali, Lanthe Kruger, Rita Yusuf, Jephat Chifamba, Conrad Kabali, Gilles Dagenais, Scott A Lear, Koon Teo, Salim Yusuf
ABSTRACT

The optimal range of sodium intake for cardiovascular health is controversial. We obtained morning fasting urine samples from 101,945 persons in 17 countries and estimated 24-hour sodium and potassium excretion (used as a surrogate for intake). We examined the association between estimated urinary sodium and potassium excretion and the composite outcome of death and major cardiovascular events. The mean estimated sodium and potassium excretion was 4.93 g per day and 2.12 g per day, respectively. With a mean follow-up of 3.7 years, the composite outcome occurred in 3317 participants (3.3%). As compared with an estimated sodium excretion of 4.00 to 5.99 g per day (reference range), a higher estimated sodium excretion (≥ 7.00 g per day) was associated with an increased risk of the composite outcome (odds ratio, 1.15; 95% confidence interval [CI], 1.02 to 1.30), as well as increased risks of death and major cardiovascular events considered separately. The association between a high estimated sodium excretion and the composite outcome was strongest among participants with hypertension (P=0.02 for interaction), with an increased risk at an estimated sodium excretion of 6.00 g or more per day. As compared with the reference range, an estimated sodium excretion that was below 3.00 g per day was also associated with an increased risk of the composite outcome (odds ratio, 1.27; 95% CI, 1.12 to 1.44). As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a reduced risk of the composite outcome. In this study in which sodium intake was estimated on the basis of measured urinary excretion, an estimated sodium intake between 3 g per day and 6 g per day was associated with a lower risk of death and cardiovascular events than was either a higher or lower estimated level of intake. As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a lower risk of death and cardiovascular events. (Funded by the Population Health Research Institute and others.).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium, in kerosene, pieces (large), ≥99.8% (sodium basis)
Sigma-Aldrich
Sodium, 25-35 wt % dispersion in paraffin
Sigma-Aldrich
Sodium, ACS reagent, dry
Sigma-Aldrich
Sodium, cubes, contains mineral oil, 99.9% trace metals basis
Sigma-Aldrich
Sodium, 99.95% trace metals basis, ingot
Sigma-Aldrich
Sodium, SAJ first grade, ≥99.5%
Sigma-Aldrich
Sodium, CP